MedPath
TGA Approval

ZEROUNT denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial (461909)

461909

ZEROUNT denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial

Amgen Australia Pty Ltd

November 5, 2024

Medicine

Medicine

Active

Registered

Active Ingredients

Denosumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZEROUNT denosumab (rch) 70mg/mL (120mg/1.7mL) solution for injection vial (461909) - TGA 批准文号 | MedPath